GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Clover Corp Ltd (ASX:CLV) » Definitions » Total Liabilities

Clover (ASX:CLV) Total Liabilities : A$19.56 Mil (As of Jan. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Clover Total Liabilities?

Clover's Total Liabilities for the quarter that ended in Jan. 2024 was A$19.56 Mil.

Clover's quarterly Total Liabilities declined from Jan. 2023 (A$25.05 Mil) to Jul. 2023 (A$19.05 Mil) but then increased from Jul. 2023 (A$19.05 Mil) to Jan. 2024 (A$19.56 Mil).

Clover's annual Total Liabilities increased from Jul. 2021 (A$20.32 Mil) to Jul. 2022 (A$27.56 Mil) but then declined from Jul. 2022 (A$27.56 Mil) to Jul. 2023 (A$19.05 Mil).


Clover Total Liabilities Historical Data

The historical data trend for Clover's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clover Total Liabilities Chart

Clover Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.61 23.92 20.32 27.56 19.05

Clover Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.39 27.56 25.05 19.05 19.56

Clover Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Clover's Total Liabilities for the fiscal year that ended in Jul. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=8.289+(9.583+-1.4085954624932E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+1.142+0.037)
=19.05

Total Liabilities=Total Assets (A: Jul. 2023 )-Total Equity (A: Jul. 2023 )
=86.202-67.151
=19.05

Clover's Total Liabilities for the quarter that ended in Jan. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6.502+(11.872+0.048000000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+1.142+0)
=19.56

Total Liabilities=Total Assets (Q: Jan. 2024 )-Total Equity (Q: Jan. 2024 )
=84.87-65.306
=19.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clover Total Liabilities Related Terms

Thank you for viewing the detailed overview of Clover's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Clover (ASX:CLV) Business Description

Traded in Other Exchanges
N/A
Address
39 Pinnacle Road, Altona North, Melbourne, VIC, AUS, 3025
Clover Corp Ltd provides nutritional and functional ingredients. The company is involved in the production of encapsulated powders, and research and product development of functional food and infant nutrition ingredients. It offers Nu-Mega Hi docosahexaenoic acid tuna oils for use in infant formula and pharmaceutical products; and Ocean Gold refined tuna oils. Its products include DHA oils, DHA powders, and Microencapsulation. Geographically, the group has a business presence in Australia, New Zealand, Asia, Europe, and the Americas. Majority of the revenue is derived from Asia.